Phase 1 Safety Study Clears Path to Test Utreloxastat in ALS Patients
Utreloxastat, an investigational therapy for ALS, was safe and displayed promising pharmacological properties in study of healthy people.
0 Comments
Phase 1 Safety Study Clears Path to Test Utreloxastat in ALS Patients
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed